Skip to main content
Craig Kessler, MD, Oncology, Washington, DC, MedStar Georgetown University Hospital

CraigKesslerMD

Oncology Washington, DC

Hematologic Oncology

Professor of Medicine, Georgetown University

Dr. Kessler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kessler's full profile

Already have an account?

Summary

  • Dr. Craig Kessler is a hematologist/oncologist in Washington, DC and is affiliated with MedStar Georgetown University Hospital. He received his medical degree from Tulane University School of Medicine and has been in practice 44 years. He specializes in hematologic oncology and is experienced in hematologic oncology, thrombotic disorders, bleeding disorders, general / benign hematology, and myeloproliferative neoplasms.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1977 - 1978
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1976 - 1977
  • Ochsner Clinic Foundation
    Ochsner Clinic FoundationResidency, Internal Medicine, 1973 - 1976
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 1973

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1981 - 2024
  • LA State Medical License
    LA State Medical License 1973 - 2008
  • VA State Medical License
    VA State Medical License 1987 - 2004
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Treatment of Venous Thromboembolism in Elite Athletes: A Suggested Approach to Individualized Anticoagulation  
    Alex C Spyropoulos, Craig M Kessler, Bhavi Pandya, Seminars in Thrombosis and Hemostasis

Abstracts/Posters

  • Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Set...
    Craig M. Kessler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Protecting Our Vulnerable, Medically Ill Patients From Venous Thromboembolism 
    60th American Society of Hematology Annual Meeting - 11/30/2018
  • Ninth Annual Hematology Conference: An Update on Selected ASH Topics 
    The University of Tennessee Graduate School of Medicine, Knoxville, Tennessee - 1/19/2013

Authored Content

  • Emicizumab Prophylaxis in Hemophilia A with InhibitorsJuly 2017

Press Mentions

  • Local Hospitals Begin Treating Coronavirus Patients with Blood from Survivors
    Local Hospitals Begin Treating Coronavirus Patients with Blood from SurvivorsApril 22nd, 2020
  • Sangamo Announces Treatment of First Patient in Clinical Trial of in Vivo Genome Editing Therapy for Hemophilia B
    Sangamo Announces Treatment of First Patient in Clinical Trial of in Vivo Genome Editing Therapy for Hemophilia BDecember 20th, 2018

Hospital Affiliations